{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T13:13:20Z","timestamp":1722086000887},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.hfc.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T19:32:11Z","timestamp":1530300731000},"page":"271-281","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis"],"prefix":"10.1016","volume":"14","author":[{"given":"Luna","family":"Gargani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Voilliot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"D\u2019Alto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gergely","family":"Agoston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Moreo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Wierzbowska-Drabik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Moggi-Pignone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10103","key":"10.1016\/j.hfc.2018.02.004_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hfc.2018.02.004_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"issue":"Suppl 3","key":"10.1016\/j.hfc.2018.02.004_bib4","first-page":"iii25","article-title":"Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis","volume":"48","author":"McLaughlin","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"145","key":"10.1016\/j.hfc.2018.02.004_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0056-2017","article-title":"Pulmonary hypertension in systemic sclerosis: different phenotypes","volume":"26","author":"Launay","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jacc.2016.05.047","article-title":"Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum","volume":"68","author":"Opitz","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25 Suppl","key":"10.1016\/j.hfc.2018.02.004_bib7","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2018.02.004_bib8","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3899\/jrheum.101243","article-title":"PHAROS Investigators. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population","volume":"38","author":"Hinchcliff","year":"2011","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.hfc.2018.02.004_bib9","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/rheumatology\/kex351","article-title":"Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension","volume":"56","author":"Connolly","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"10.1016\/j.hfc.2018.02.004_bib10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2 Suppl 76","key":"10.1016\/j.hfc.2018.02.004_bib11","first-page":"31","article-title":"Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort","volume":"31","author":"Iudici","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.hfc.2018.02.004_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5301\/jsrd.5000246","article-title":"Prevalence and incidence of pulmonary arterial hypertension: 10-year follow-up of an unselected systemic sclerosis cohort","volume":"2","author":"Vandecasteele","year":"2017","journal-title":"J scleroderma Relat Disord"},{"issue":"5","key":"10.1016\/j.hfc.2018.02.004_bib13","first-page":"1005","article-title":"Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease","volume":"34","author":"Launay","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.hfc.2018.02.004_bib14","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.hfc.2018.02.004_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.hfc.2018.02.004_bib16","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib17","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1378\/chest.12-0653","article-title":"Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era","volume":"144","author":"Rubenfire","year":"2013","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.hfc.2018.02.004_bib18","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis","volume":"65","author":"Lefevre","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"26","key":"10.1016\/j.hfc.2018.02.004_bib19","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hfc.2018.02.004_bib20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Galie","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hfc.2018.02.004_bib21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.hfc.2018.02.004_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2016-210236","article-title":"Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial","volume":"76","author":"Coghlan","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.hfc.2018.02.004_bib23","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201507-1398OC","article-title":"Ambrisentan and tadalafil up-front combination therapy in scleroderma-associated pulmonary arterial hypertension","volume":"192","author":"Hassoun","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.hfc.2018.02.004_bib24","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.30541","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival","volume":"63","author":"Humbert","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.hfc.2018.02.004_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfmuller","year":"2007","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.hfc.2018.02.004_bib26","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.34501","article-title":"Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension","volume":"64","author":"Gunther","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.hfc.2018.02.004_bib27","article-title":"Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: characteristics and survival of patients from the Spanish RESCLE Registry","author":"Mari-Alfonso","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.hfc.2018.02.004_bib28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.hfc.2018.02.004_bib29","first-page":"2398","article-title":"Scleroderma patients with combined pulmonary hypertension and interstitial lung disease","volume":"30","author":"Chang","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.hfc.2018.02.004_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.24267","article-title":"Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease","volume":"60","author":"Mathai","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.1780340405","article-title":"Predictors of survival in systemic sclerosis (scleroderma)","volume":"34","author":"Altman","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.hfc.2018.02.004_bib32","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/art.30423","article-title":"Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies","volume":"63","author":"Le Pavec","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1378\/chest.10-2473","article-title":"Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease","volume":"140","author":"Launay","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hfc.2018.02.004_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MCP.0b013e328356803b","article-title":"Combined pulmonary fibrosis and emphysema in connective tissue disease","volume":"18","author":"Cottin","year":"2012","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib35","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/art.39528","article-title":"Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension","volume":"68","author":"Antoniou","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.hfc.2018.02.004_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.hfc.2018.02.004_bib37","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/ard.2008.095836","article-title":"Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients","volume":"68","author":"Hachulla","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hfc.2018.02.004_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2016.04.158","article-title":"Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use","volume":"217","author":"Mavrogeni","year":"2016","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2018.02.004_bib39","first-page":"656","article-title":"A\u00a0controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)","volume":"17","author":"Follansbee","year":"1990","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib40","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00025413","article-title":"Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?","volume":"42","author":"Coghlan","year":"2013","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1183\/09031936.00091212","article-title":"High prevalence of occult left heart disease in scleroderma-pulmonary hypertension","volume":"42","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.08-2784","article-title":"Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure","volume":"136","author":"Halpern","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.11-1387","article-title":"Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18\u00a0mm Hg: insights from the REVEAL registry","volume":"143","author":"Frost","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.hfc.2018.02.004_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5301\/jsrd.5000235","article-title":"Complex Pathophysiology of Pulmonary Hypertension Associated with Systemic Sclerosis: Potential Unfavorable Effects of Vasodilators","volume":"2","author":"Shirai","year":"2017","journal-title":"J scleroderma Relat Disord"},{"issue":"8","key":"10.1016\/j.hfc.2018.02.004_bib45","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/echo.13594","article-title":"Imaging the right heart pulmonary circulation unit: insights from advanced ultrasound techniques","volume":"34","author":"Ferrara","year":"2017","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.echo.2014.09.004","article-title":"Echocardiographic prediction of pre- versus postcapillary pulmonary hypertension","volume":"28","author":"D'Alto","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.hfc.2018.02.004_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2018.02.004_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-7120-8-25","article-title":"Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis","volume":"8","author":"Serra","year":"2010","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.hfc.2018.02.004_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-7120-11-7","article-title":"Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension","volume":"11","author":"Granstam","year":"2013","journal-title":"Cardiovasc Ultrasound"},{"issue":"Suppl 5","key":"10.1016\/j.hfc.2018.02.004_bib50","doi-asserted-by":"crossref","first-page":"v42","DOI":"10.1093\/rheumatology\/ken284","article-title":"Right ventricular function in scleroderma-related pulmonary hypertension","volume":"47","author":"Vonk Noordegraaf","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.hfc.2018.02.004_bib51","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00025607","article-title":"Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension?","volume":"30","author":"Huez","year":"2007","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hfc.2018.02.004_bib52","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1183\/09031936.00135407","article-title":"Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension","volume":"31","author":"Overbeek","year":"2008","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.hfc.2018.02.004_bib53","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.hfc.2018.02.004_bib54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2018.02.004_bib55","article-title":"Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study","author":"D'Alto","year":"2017","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.hfc.2018.02.004_bib56","article-title":"Mechanics and prognostic value of left and right ventricular dysfunction in patients with systemic sclerosis","author":"Saito","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.hfc.2018.02.004_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003792","article-title":"Unique abnormalities in right ventricular longitudinal strain in systemic sclerosis patients","volume":"9","author":"Mukherjee","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.hfc.2018.02.004_bib58","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10067-016-3279-9","article-title":"Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study","volume":"35","author":"D'Andrea","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-7120-8-3","article-title":"Early right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: a Doppler Tissue and Speckle Tracking echocardiography study","volume":"8","author":"Schattke","year":"2010","journal-title":"Cardiovasc Ultrasound"},{"issue":"3","key":"10.1016\/j.hfc.2018.02.004_bib60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/annrheumdis-2011-201072","article-title":"Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis","volume":"72","author":"Barskova","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13075-017-1409-7","article-title":"Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review","volume":"19","author":"Wang","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.hfc.2018.02.004_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00578-2017","article-title":"An official European Respiratory Society statement: pulmonary haemodynamics during exercise","volume":"50","author":"Kovacs","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hfc.2018.02.004_bib63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.euje.2005.12.002","article-title":"Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: pulmonary hypertension assessment and screening evaluation using stress echocardiography (PHASE-I)","volume":"7","author":"Collins","year":"2006","journal-title":"Eur J Echocardiogr"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1378\/chest.130.1.176","article-title":"Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma","volume":"130","author":"Alkotob","year":"2006","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.hfc.2018.02.004_bib65","first-page":"1812","article-title":"Prevalence of exercise pulmonary arterial hypertension in scleroderma","volume":"35","author":"Callejas-Rubio","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.hfc.2018.02.004_bib66","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1196\/annals.1422.031","article-title":"Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis","volume":"1108","author":"Pignone","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.hfc.2018.02.004_bib67","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1183\/09031936.00076009","article-title":"Exercise stress echocardiography for the study of the pulmonary circulation","volume":"35","author":"Argiento","year":"2010","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.hfc.2018.02.004_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/hrt.2010.203471","article-title":"Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis","volume":"97","author":"D'Alto","year":"2011","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.hfc.2018.02.004_bib69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ahj.2012.10.020","article-title":"Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study","volume":"165","author":"Gargani","year":"2013","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2018.02.004_bib70","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijcard.2014.02.042","article-title":"Determinants of exercise-induced pulmonary arterial hypertension in systemic sclerosis","volume":"173","author":"Voilliot","year":"2014","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2018.02.004_bib71","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/art.38043","article-title":"Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension","volume":"65","author":"Codullo","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib72","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.acvd.2015.11.014","article-title":"Prediction of new onset of resting pulmonary arterial hypertension in systemic sclerosis","volume":"109","author":"Voilliot","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.hfc.2018.02.004_bib73","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jacc.2015.05.032","article-title":"Prediction of future overt pulmonary hypertension by 6-min walk stress echocardiography in patients with connective tissue disease","volume":"66","author":"Kusunose","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2018.02.004_bib74","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/art.38172","article-title":"Recommendations for screening and detection of connective-tissue disease associated pulmonary arterial hypertension","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib75","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.23187","article-title":"High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis","volume":"58","author":"Allanore","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.hfc.2018.02.004_bib76","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar3876","article-title":"N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study","volume":"14","author":"Thakkar","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.hfc.2018.02.004_bib77","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.hfc.2018.02.004_bib78","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/annrheumdis-2017-211480","article-title":"Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort","volume":"77","author":"Mihai","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hfc.2018.02.004_bib80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-015-0517-5","article-title":"A\u00a0comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis","volume":"17","author":"Hao","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.hfc.2018.02.004_bib81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS) cohort study","volume":"44","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.hfc.2018.02.004_bib82","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02275-2016","article-title":"Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort","volume":"49","author":"Vandecasteele","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hfc.2018.02.004_bib83","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s13075-014-0493-1","article-title":"Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study","volume":"16","author":"Visovatti","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.hfc.2018.02.004_bib84","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/rheumatology\/kex435","article-title":"Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort","volume":"57","author":"Hoffmann-Vold","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"15","key":"10.1016\/j.hfc.2018.02.004_bib85","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.hfc.2018.02.004_bib86","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1002\/art.27695","article-title":"Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities","volume":"62","author":"Saggar","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.hfc.2018.02.004_bib87","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/annrheumdis-2011-200546","article-title":"Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry","volume":"71","author":"Bae","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713618300187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713618300187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T01:14:10Z","timestamp":1530321250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713618300187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1551713618300187"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2018.02.004","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}